Skip to main content
Be The Investor
BTI Market Newsearnings
Back to News

Northrop Grumman's Record $110 Billion Backlog Lifts the 2026 Outlook

Northrop Grumman's Record $110 Billion Backlog Lifts the 2026 Outlook

Northrop Grumman posted 7% sales growth, a 1.5 book-to-bill ratio and record backlog. The raised outlook is supported by demand, while execution on Sentinel remains the largest program test.

Northrop Grumman ended the third quarter with $109.6 billion of backlog, rounded to a record $110 billion, after new awards exceeded quarterly sales by 50%. That demand translated into 7% revenue growth and a higher 2026 outlook, giving investors a stronger basis for the company's recent share-price gains than retail sentiment or weekly momentum.

Orders outpaced revenue

Third-quarter sales rose to $11.1 billion from $10.4 billion a year earlier. Net awards totaled $16.4 billion, producing a book-to-bill ratio of 1.5. A ratio above 1 means the company booked more work than it recognized as revenue during the period.

Loading market context

Major awards included $2 billion for Sentinel, $1.4 billion related to Virginia-class submarines and $1.3 billion for the F-35 program. The backlog provides long-duration visibility, but it is not cash in the bank. Program schedules, appropriations, contract terms and execution determine when backlog becomes revenue and profit.

Sentinel is both growth driver and risk

Northrop said the Sentinel intercontinental ballistic missile program completed the first full vertical assembly of an inert missile at Vandenberg Space Force Base. The Air Force also approved design maturity for a first flight to proceed in 2027.

Those milestones are meaningful because Sentinel is expected to support growth for years. They do not remove the risk attached to a complex, long-cycle government program. Cost performance, schedule discipline and customer funding remain critical, especially as Sentinel transitions from development toward production.

The outlook improved, with caveats

Northrop raised guidance for key 2026 financial measures. Diluted earnings per share were $7.89 in the quarter, and the company increased the midpoint of its adjusted earnings outlook. Sales growth, a large backlog and a stronger segment operating-income range support the case for continued earnings expansion.

Investors should still separate the quantity of orders from their quality. A large fixed-price award can pressure margins if costs rise, while a cost-type contract shifts more risk to the customer. The mix of awards matters alongside the headline backlog.

The quarter strengthens Northrop's investment case because demand is visible and management raised its expectations. The next evidence will be execution: converting the $110 billion backlog into revenue at stable margins while keeping Sentinel and the company's expanding satellite workload on schedule.